Study
This 2025 clinical trial demonstrated that Nutrafol, a blend of standardized botanicals and nutrients, improved hair growth and scalp coverage in m...
In plain language
This 2025 clinical trial demonstrated that Nutrafol, a blend of standardized botanicals and nutrients, improved hair growth and scalp coverage in men with mild-to-moderate thinning. The study design was strong, statistically valid, and safe for long-term use. While younger participants limit direct senior applicability, the findings are relevant for age-related hair loss.
Use the full description to understand the study design, methods, and the limits of the findings.
This randomized, double-blind, placebo-controlled trial evaluated a nutraceutical supplement (Nutrafol) for male hair thinning. Over 24 weeks, participants receiving Nutrafol showed significant increases in hair count, thickness, and self-perceived fullness compared to placebo. The supplement was well tolerated with no major adverse effects.
Open the original publication for the complete methods, outcomes, and source material.
Published December 2025
Opens at the publisher · external site · may require institutional access
The study is methodologically robust, employing a strong design with effective bias control and statistical integrity. However, its relevance to seniors is limited due to the younger participant demographic. Replication is needed to confirm findings.
| Category | Score | Rating |
|---|---|---|
| Study Design / Evidence Level | 9.0/10 | |
| Bias & Methods | 9.0/10 | |
| Statistical Integrity | 8.0/10 | |
| Transparency | 8.0/10 | |
| Conflict of Interest Disclosure | 9.0/10 | |
| Replication / External Validation | 6.0/10 | |
| Relevance to Seniors | 5.0/10 | |
| Journal Quality | 8.0/10 |
While the study shows promise for addressing hair thinning, its direct applicability to seniors is limited. Future research should focus on older populations to enhance relevance.
Build a personalized plan using research-backed studies, conditions, and treatments.